Physician profile
Jae Kim
NPI 1780079905
$1,654.47
in general payments reported to CMS, 2019-2025
27 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $222 · 2021: $334 · 2022: $166 · 2023: $287 · 2024: $290 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $171.38 | 2019-2024 | |
| Abbott Laboratories | $150.50 | 2020-2022 | |
| Amgen INC. | $141.52 | 2021-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $138.83 | 2024-2025 | |
| Medtronic Vascular, INC. | $102.10 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $91.13 | 2020-2024 | Xarelto |
| Pfizer INC. | $84.93 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $82.29 | 2023 | Verquvo |
| Atricure, INC. | $74.23 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $66.72 | 2022-2024 | |
| Cardinal Health 200 LLC | $64.93 | 2019 | |
| Cvrx, INC. | $61.80 | 2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.00 | 2021 | |
| Medtronic, INC. | $49.65 | 2021-2024 | Reveal Linq |
| E.R. Squibb & Sons, L.L.C. | $47.10 | 2022-2024 | Camzyos |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $46.69 | 2024 | |
| Abiomed | $38.07 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $34.12 | 2020-2023 | Farxiga |
| Cardiovascular Systems INC. | $23.47 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.72 | 2023 | Trulance |
| Chiesi USA, INC. | $20.70 | 2020 | |
| Novo Nordisk INC | $20.14 | 2024 | Ozempic, Rybelsus |
| Philips North America LLC | $17.21 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $16.69 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $14.10 | 2021 | |
| Verge Medical, INC. | $13.32 | 2020 | |
| Zoll Circulation INC | $9.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jae Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.